BioCentury
ARTICLE | Clinical News

Hexvix: Began Phase III trial enrollment

October 8, 2001 7:00 AM UTC

PhotoCure ASA (OSE:PHO), Oslo, Norway Product: Hexvix Business: Diagnostics/Imaging Therapeutic category: Test Target: NA Description: Fluorescence cystoscopy Indication: Detect bladder cancer Endpoi...